|Publication number||US7785358 B2|
|Application number||US 11/282,070|
|Publication date||Aug 31, 2010|
|Priority date||Nov 3, 2000|
|Also published as||CA2427893A1, CA2427893C, DE60138420D1, EP1363577A2, EP1363577A4, EP1363577B1, EP1834668A1, US6673096, US7033382, US20020111656, US20040093047, US20060161228, WO2002035983A2, WO2002035983A3|
|Publication number||11282070, 282070, US 7785358 B2, US 7785358B2, US-B2-7785358, US7785358 B2, US7785358B2|
|Original Assignee||Eleme Medical, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (24), Non-Patent Citations (1), Referenced by (2), Classifications (14), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application claims the benefit of and is a continuation of co-pending U.S. Utility application Ser. No. 10/701,991, filed Nov. 5, 2003, which is a continuation of U.S. patent application Ser. No. 10/000,459, filed Nov. 2, 2001 and later issued on Jan. 6, 2004 as U.S. Pat. No. 6,673,096, which claimed priority to U.S. Provisional Application No. 60/245,948, filed Nov. 3, 2000, for all subject matter common to all applications. The disclosure of said Utility applications are hereby incorporated by reference in their entirety.
The invention relates to treatment of a physical condition, and more particularly relates to a system and corresponding method of use for the treatment of body tissue, including reducing cellulite.
Cellulite is not only prevalent in the overweight. It is estimated that between 90% and 98% of the total female adult population have had, will have, or currently do have, a desire to reduce an amount of cellulite. The male population also struggles with its desire to reduce cellulite amounts.
Once cellulite begins, it is chronic and spontaneously irreversible (without specific treatment). If extracted and chemically analyzed, cellulite is a jelly-like substance composed of water and fat. Cellulite becomes trapped in tissues. Unlike ordinary fat, cellulite is not readily available to the organism. Because it is trapped, it is relatively isolated from the natural processes of absorption and elimination.
Secondarily, cellulite interferes with circulation. The formation of cellulite partially occurs due to venous and lymphatic stagnation. The vicious cycle is then closed and tends to perpetuate itself.
Cellulite is a generalized condition that is fundamentally based on nutrition. As fat cells increase in volume and infiltration, they add to an already existing circulatory disturbance. This leads to a decrease in the local metabolic rate, which helps perpetuate the cellulite cycle. The sticky, fatty masses find locations in the connective tissue (otherwise known as interstitial tissue) between the skin and muscle in the subcutaneous layer. When there is a disturbance in the connective tissue, additional problems result. The additional problems occur in part because the connective tissue envelops all internal organs including the lymphatic system, which contributes to the pathway of all nutrients and wastes to and from the cells.
Increases of cellulite deposits literally waterlog the connective tissue, which eventually breaks down. The connective tissue then attempts to repair itself, eventually forming a fibrous scar tissue. The newly thickened tissue then traps more fat and water, which again develops cellulite.
A number of non-invasive methods currently exist that attempt to reduce cellulite on a temporary basis. These methods primarily involve the application of topical agents to reduce the appearance of cellulite on the thigh, which have been reported to be effective as a temporary means of cellulite reduction. Other methods of cellulite reduction involve targeted surgical adipose tissue resection in the fatty layers of the subcutaneous tissue. This method is considered an invasive procedure with potential risks and complications including pain, numbness, surface contour irregularity, and death. Other non-surgical but invasive means of cellulite reduction currently being investigated include methods of fat reduction by direct injection of antibodies to native fat, or injection of agents that otherwise accelerate resorption of fat.
There is a need for a tissue treatment system that treats body tissue, including effectively and efficiently reducing the occurrence and existence of cellulite in a patient. The present invention is directed toward further solutions to address this need. A tissue treatment system is provided that includes a radiation-emitting device and a massaging mechanism. In accordance with one embodiment, the radiation-emitting device is a laser and the massaging mechanism is an automated mechanical massaging mechanism.
The radiation-emitting device can emit radiation in the visible (e.g., light) and infrared wavelengths. In one example embodiment, the radiation-emitting device emits radiation in a concentric combination of infrared and visible laser light.
The teachings of the present invention further include a method of using the tissue treatment system having a radiation-emitting device and a massaging mechanism. The method includes exposing a skin surface of a patient to radiation emitted from the radiation-emitting device at predetermined wavelengths for predetermined periods of time. The radiation can be applied continuously or intermittently according to a preferred regimen. The method further provides for massaging the exposed skin surface of the patient with the massaging mechanism.
An additional step of calculating the predetermined wavelengths and the predetermined periods of time based at least partially on a measurement of cellulite in an area of the skin surface being treated is also provided.
The step of exposing the skin surface can include exposing the skin surface to laser induced radiation. The laser radiation can apply a concentric combination of infrared and visible laser light to the skin surface.
The method can further include the step of exposing the skin surface to an application of infrared radiation after exposure to the laser radiation. The application of infrared radiation can occur in a continuous wave. The application of infrared radiation can also occur at predetermined locations on the exposed skin corresponding to lymphatic drainage meridians.
The step of massaging the exposed skin surface can utilize a mechanical massage mechanism. The step of massaging the exposed skin can be executed by massaging from points distal from a heart of the patient to points proximal to the heart of the patient to encourage fluid flow toward the heart. Further, the step of massaging the exposed skin can include massaging in predetermined patterns of motion.
The tissue treatment system, and corresponding method of use, can be effective in treating a selected condition, such as unwanted tissue, edema, overactive sweat glands, cysts, lipomas, psoriatic tissue, acne, excess lymphatic fluid and tissue, varicose veins, telengiectasias, pain, inflammation, inflammatory products, and body toxins.
The aforementioned features and advantages, and other features and aspects of the present invention, will become better understood with regard to the following description and accompanying drawings, wherein:
The present invention generally relates to treating a selected patient condition, and preferably relates to tissue treatment. A tissue treatment system of the present invention applies laser radiation to an area targeted for, e.g., cellulite reduction, in a predetermined wavelength, or combination of wavelengths, intervals, periods, and patterns. The application of infrared radiation can optionally follow. Subsequent to the application of infrared radiation, the tissue treatment system massages the area targeted for cellulite reduction using a predetermined combination of massage techniques. Cellulite reduction results from the combined laser and massage applications. Other tissue treatments are possible with variation of the laser and massage applications. The new regimen can be determined by the ordinarily skilled artisan in light of the teachings herein.
Referring now in detail to the drawings wherein like parts are designated by like reference numerals throughout,
Cellulite represents the excessive accumulation of fat cells within areas of connective tissue (in the subcutaneous layer) whereby additional microcirculatory and biochemical changes have taken place. This localized form of fat tends to affect the thighs, the medial side of the knees, the buttocks, and the medial and outer sides of the arms, the nape, abdomen, flank, and the ankles. In cellulite states, the fundamental substance of the connective tissue increases its degree of fluid retention and viscosity therefore resulting in poor capillary exchange, which interferes with the mobilization of the excess deposits of fatty tissue.
According to one aspect of the present invention a condition or tissue treatment system 10 is provided. The tissue treatment system 10, through a process of transcutaneous laser stimulation combined with infrared radiation treatment and subsequent skin massage, has many different effects. For the purpose of illustrating the tissue treatment system 10, the example effect of cellulite reduction will be described herein. However, it should be noted that the teachings of the present invention can be applied to a plurality of tissue treatments, as characterized below. For the instance of cellulite reduction, the application of infrared radiation and skin massage reduces the thickness of fat located in a subcutaneous location of a patient.
Turning first to
The controller or data processing device can be a programmable or programmed device that responds to a specific set of instructions in a well-defined manner and can execute a set of instructions. The device can include one or more of a storage device, which enables the computing apparatus to store, at least temporarily, data, information, and programs (e.g., RAM or ROM); a mass storage device for substantially permanently storing data, information, and programs (e.g., disk drive or tape drive); an input device through which data and instructions enter the computing apparatus (e.g., keyboard, mouse, or stylus); an output device to display or produce results of computing actions (e.g., display screen, printer, or infrared, serial, or digital port); and a central processing unit including a processor for executing the specific set of instructions.
The tissue treatment system 10 further includes a mechanical massaging mechanism 20 for use in conjunction with the laser 12. The mechanical massaging mechanism 20 can apply different massage techniques to the patient. By mechanical massaging mechanism 20 what is meant is any suitable device for applying mechanical or electrical physical stimulus to an area of a patient's skin or body tissue. For example, the mechanical massaging mechanism 20 can include one or more spherical components, rolling components, kneading components, vibrating components, and the like. The mechanical massaging mechanism 20 can execute different massage techniques as known to those of ordinary skill in the art, and have any selected shape or take any selected form.
The operation of the tissue treatment system 10 according to one aspect of the present invention is illustrated in
The tissue treatment system 10 applies at least two different laser 12 wavelengths to the patient during the course of the application. The radiation can be emitted at different wavelengths, at different intervals, and for different time durations. First, the laser 12 projects radiation having wavelengths in a concentric combination of infrared and visible laser light, for example between about 650 nanometers and about 1295 nanometers.
The duration, power, and wavelengths of the application of the laser 12 depends primarily on a formulation of different factors, such as calf circumference, thigh circumference, abdominal circumference, hip circumference, patient weight, and patient height. For example, a patient having a thigh circumference of 38 cm, calf circumference of 31 cm, abdominal circumference of 76 cm, hip circumference of 82 cm, weight of 62 kg, ideal body weight of 50 kg according to Standard Metropolitan Life Insurance Company Tables, and height of 5 feet 3 inches, would be exposed to the rastered radiation for 6.4 minutes per area. The time duration for exposure of each area on the skin surface 14 is calculated based on the following expression: (Hip Circumference in cm)/(Abdominal Circumference in cm)×(Weight in kgs)/(Ideal Body Weight in kgs)×(Calf Circumference in cm+Thigh Circumference in cm)×Reduction Factor=Time in Minutes. Ideal Body Weight (“IBW”) is as defined by Standard Metropolitan Life Insurance Company tables for IBW calculated from the patient's height. The Reduction Factor is 0.07 with a minimum exposure of 5.5 minutes per area. The maximum exposure per area for a majority of the patients is about 12 minutes. However, this number may vary depending on the above variables. Again, the power of the laser 12 in the described embodiment is fixed. However, a laser having variable power settings can be employed, and the above relationship of variables adjusted for different power settings.
The typical exposure time per area being exposed is between about five and twelve minutes for an individual female adult of average build. For example, the thigh area can be treated in three sections, each area encompassing 120 degrees of the thigh with approximately 20% overlap. Thus, for each thigh, the laser treatment time is approximately three times the duration of exposure for each area, or eighteen to thirty minutes per limb. The duration of exposure varies depending on the actual values of the above-mentioned variables. The laser 12 is delivered as a continuous wave beam rastered across the skin surface 14. The entire skin area to be treated may be covered by a single scan at a rate of about 1 Hz.
Upon completion of the laser scan session, an infrared radiation emission is then administered to the skin surface 14 at sixteen discrete sites along each single thigh (step 32). The sites are at approximately the lymphatic drainage meridians known to those of ordinary skill in the art. Each site is exposed for a period of approximately 30 seconds. The sites correspond to different lymphatic drainage points, and are different for different parts of the body. Further, the infrared radiation can be applied in a number of different patterns, such as oval, square, circle, etc., to most efficiently cover a target area as required. A more typical application involves a generally circular motion, with a final whisking in the general direction of the heart.
The laser treatment heats deep tissue within the body of the patient at the targeted locations exposed to the laser 12. The deep heating of the laser 12 can also be delivered to deep muscle, tendon, fascia, and bone structures within the body of the patient. Concentrated delivery of heat into the fat layer can cause the desired lipolysis, which is the hydrolysis of lipids, i.e., the decomposition of the organic compounds forming the cellulite.
Following the application of the laser 12 in the different wavelength combinations, the mechanical massaging mechanism 20 applies a vigorous massage to the portions of the skin surface 14 that were treated with the laser and infrared wavelengths (step 34). As an example embodiment, a massaging machine made by Spa-de-Soleil formed the massage portion of the tissue treatment system 10 and was utilized to execute the massage. The mechanical massaging mechanism 20 applies a number of predetermined different massage patterns and techniques to the areas targeted for cellulite reduction. In the example of a thigh, each side of the thigh is massaged for approximately 4 to 6 minutes, however, the duration of the massage can vary to the extent required for optimal cellulite reduction as specified by the particular circumstances surrounding the patient. The massaging motion occurs from a point distal from the heart to points proximal to the heart to encourage fluid flow toward the heart.
Fat is a component of cellulite. Therefore, reduction of fat by the laser application reduces the appearance of cellulite. However, if an individual does not maintain an appreciable level of cellulite, that reduction and ablation of fat results in other benefits, such as reduction of blood pressure, and reduced insulin requirements. A visible reduction in cellulite may not occur in such an instance, because the cellulite was not visible prior to treatment.
In a further example embodiment, an experimental application was executed, the results of which are plotted in
An advantage of the present invention is that cellulite levels can be reduced with no “down time” experienced. While other methods of cellulite removal may result in permanent removal of fat, such other methods are more costly, typically require anesthesia, can be painful, and can have further complications including extended “down time”.
The teachings of the present invention can be applied in the treatment of other maladies. For example, the method of the present invention can be used for ablation of any unwanted tissue, reduction of edema, treatment of overactive sweat glands, cysts, lipomas, psoriatic tissue, excess lymphatic fluid and tissue, varicose veins, acne, telengiectasias, pain, inflammation, inflammatory products, and other toxins. The method can also be utilized to increase muscle bulk, cause muscle warming, stimulation of bone healing, treatment for “shin splints”, tendinitis, tenosynovitis, bone regeneration, and relief of neuralgias, neuromas, and neuropraxias. In each instance, the specific laser wavelengths are adjusted and the aggressiveness and pattern of the massage portion of the treatment varies to correspond to the particular treatment regimen being followed.
Numerous modifications and alternative embodiments of the invention will be apparent to those skilled in the art in view of the foregoing description. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the best mode for carrying out the invention. Details of the structure may vary substantially without departing from the spirit of the invention, and exclusive use of all modifications that come within the scope of the appended claims is reserved. It is intended that the invention be limited only to the extent required by the appended claims and the applicable rules of law.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US1955863||Feb 19, 1931||Apr 24, 1934||Schmidt Gustave Franz||Electro-therapeutic and mechanical vibratory device|
|US2231095||Mar 29, 1939||Feb 11, 1941||Faust Fritz M||Massaging device or like implement|
|US2490074||Dec 11, 1946||Dec 6, 1949||Amos R Marty||Light ray and massage therapy|
|US5176130 *||Oct 10, 1991||Jan 5, 1993||Interport International, Inc.||Infrared massage device|
|US5330416 *||May 19, 1992||Jul 19, 1994||France Bed Co., Ltd.||Rolling massage apparatus with vibratory support|
|US5336159 *||Aug 25, 1992||Aug 9, 1994||Cheng Tzu Keng||Infrared massager|
|US5464436||Apr 28, 1994||Nov 7, 1995||Lasermedics, Inc.||Method of performing laser therapy|
|US5551949 *||Dec 2, 1994||Sep 3, 1996||Interport International, Inc.||Infrared massage device|
|US5587396||Aug 26, 1994||Dec 24, 1996||Mary Kay Inc.||Method of ameliorating cellulite by disrupting the barrier function of the stratum corneum|
|US6039702 *||Jul 28, 1997||Mar 21, 2000||Jb Research, Inc.||Microcontroller based massage system|
|US6090101||Dec 10, 1997||Jul 18, 2000||Quon; David K.||Method and apparatus for permanent hair removal|
|US6149611||Apr 19, 1999||Nov 21, 2000||Chen; Kim-Chu||Foot massager|
|US6193678||Jun 26, 1998||Feb 27, 2001||Sammy S. Brannon||Massaging system|
|US6413267 *||Aug 9, 1999||Jul 2, 2002||Theralase, Inc.||Therapeutic laser device and method including noninvasive subsurface monitoring and controlling means|
|US6443915 *||Dec 6, 1999||Sep 3, 2002||Hyun-Bae Hwang||Control device and method of portable skin beautifying apparatus|
|US7033382||Nov 5, 2003||Apr 25, 2006||Biocellulase, Inc.||System and method for tissue treatment|
|US7217265 *||May 18, 2005||May 15, 2007||Cooltouch Incorporated||Treatment of cellulite with mid-infrared radiation|
|US20020058892 *||Oct 22, 1998||May 16, 2002||James V. Young||Massage apparatus|
|US20020193831||Apr 25, 2002||Dec 19, 2002||Smith Edward Dewey||Method and apparatus for the treatment of cosmetic skin conditions|
|US20030069618 *||Apr 25, 2002||Apr 10, 2003||Smith Edward Dewey||Method, kit and device for the treatment of cosmetic skin conditions|
|DE3905517C1||Feb 23, 1989||Mar 1, 1990||Hans-Christian 7560 Gaggenau De Ruerup||Humidifying, heating, vibrating, electrifying and illuminating therapeutic ball massage roller|
|DE19914979A1||Apr 1, 1999||Sep 16, 1999||Pierre Nicolas Foss||Fat tissue reduction method for localized fat tissue reduction for cosmetic reasons|
|EP1008366A1||Dec 7, 1999||Jun 14, 2000||Hwang, Myun-Bae||Portable skin beautifying apparatus|
|WO1999029245A1 *||Dec 10, 1998||Jun 17, 1999||Quon David W||Method and apparatus for permanent hair removal|
|1||European Communication for Application No. 01992522.1-2305, dated Feb. 19, 2008.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8551147 *||Jun 1, 2009||Oct 8, 2013||Hangzhou Dalishen Medical Device Ltd.||Hypertension therapy instrument and method for treating hypertension|
|US20100305667 *||Jun 1, 2009||Dec 2, 2010||Hangzhou Dalishen Medical Device Ltd.||Hypertension therapy instrument and method for treating hypertension|
|U.S. Classification||607/89, 601/15, 606/9, 128/898, 607/88|
|International Classification||A61N5/067, A61H1/00, A61N5/06|
|Cooperative Classification||Y10S601/05, A61N2005/067, A61N2005/0642, A61N2005/0659, A61N5/0616|
|Feb 21, 2006||AS||Assignment|
Owner name: BIOCELLULASE, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LACH, ELLIOT;REEL/FRAME:017278/0759
Effective date: 20060201
|Feb 5, 2008||AS||Assignment|
Owner name: ELEME MEDICAL INC., NEW HAMPSHIRE
Free format text: CHANGE OF NAME;ASSIGNOR:BIOCELLULASE, INC.;REEL/FRAME:020468/0352
Effective date: 20070312
|Feb 11, 2011||AS||Assignment|
Owner name: CYNOSURE, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ELEME MEDICAL, INC.;REEL/FRAME:025783/0465
Effective date: 20110131
|Jan 29, 2014||FPAY||Fee payment|
Year of fee payment: 4